Venture Capital investors in the Netherlands

M Ventures is the strategic, corporate venture capital arm of Merck investing in Biotechnology – with verticals in Healthcare and Life Science tools – and Technology – with verticals in Semiconductors and Displays as well as Sustainable Manufacture.

M Ventures invests, with dual strategic and financial foci, into visionary companies that find new ways to: treat the most challenging diseases, empower scientists with cutting-edge research and development tools, develop new solutions that change the way in which information is accessed, stored, processed, and displayed and address some of the most complex challenges in sustainability and technology convergence.

The fund has the mandate to invest in four focus areas: Healthcare, Life Sciences, Electronics and Frontier Tech and Sustainability, in alignment with the strategic interests of Merck’s business areas.